Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
12112studies shown
Showing 5,221-5,232 of 12,112
Other study type icon
CompletedNCT05486312

7-week Study With CT-155 in People With Schizophrenia

This study is completed. It focuses on schizophrenia and currently lists study information in the United States.

Multiple locations, including Culver City
SchizophreniaOtherFrom 18 Years to 64 Years
Countries
United States
Sponsor
Click Therapeutics, Inc.
Condition
Schizophrenia
Other study type icon
CompletedNCT03379597

Dietary Fiber and Probiotics Treatment for schizophrenia

This study is completed in China. It is testing dietary Fiber and Probiotics Treatment for schizophrenia.

In Changsha
Bipolarity, SchizophreniaOtherFrom 18 Years to 65 Years
Countries
China
Sponsor
Central South University
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT03508700

TNX-102 SL 5.6 mg Taken Daily at Bedtime for PTSD

This study is completed in the United States. 6 mg Taken Daily at Bedtime for PTSD.

Multiple locations, including Little Rock
PTSDDrugA study involving a medication or substance.From 18 Years to 75 Years
Countries
United States
Sponsor
Tonix Pharmaceuticals, Inc.
Condition
PTSD
Drug study icon
OngoingEUCTR 2018-003252-20

Pimavanserin for depression

This study is ongoing in the United Kingdom, in Slovakia, in Poland, .... It is testing pimavanserin for depression.

In United Kingdom
DepressionOther
Countries
United Kingdom, Slovakia, Poland, ...
Sponsor
ACADIA Pharmaceuticals Inc
Condition
Depression
Other study type icon
TerminatedEUCTR 2016-003435-38

Pimavanserin for schizophrenia

This study was terminated in Hungary, in Spain, in Bulgaria, .... It is testing pimavanserin for schizophrenia.

In Hungary
SchizophreniaOther
Countries
Hungary, Spain, Bulgaria, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.